| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 | Sep'16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating expenses: | |||||||||||||
Research and development | |||||||||||||
109,193 | 109,450 | 103,403 | 87,536 | 60,812 | 50,337 | 38,228 | 33,494 | 30,307 | 22,894 | 21,660 | 0 | 0 | 0 |
Selling, general, and administrative | |||||||||||||
41,587 | 36,550 | 35,524 | 33,528 | 31,124 | 28,080 | 24,021 | 17,797 | 12,717 | 9,518 | 6,170 | 0 | 0 | 0 |
Total operating expenses | |||||||||||||
150,780 | 146,000 | 138,927 | 121,064 | 91,936 | 78,417 | 62,249 | 51,291 | 43,024 | 32,412 | 27,830 | 0 | 0 | 0 |
Loss from operations | |||||||||||||
-150,780 | -146,000 | -138,927 | -121,064 | -91,936 | -78,417 | -62,249 | -51,291 | -43,024 | -32,412 | -27,830 | 0 | 0 | 0 |
Other income (expense): | |||||||||||||
Revaluation of Series A Investor Instrument and Series A Investor Right/Obligation | |||||||||||||
- | - | - | - | - | - | - | - | - | - | 0 | 0 | - | - |
Interest income, net | |||||||||||||
4,861 | 5,271 | 5,647 | 6,101 | 5,357 | 4,353 | 3,161 | 1,654 | 1,079 | 566 | 124 | 0 | 0 | 0 |
Total other income, net | |||||||||||||
4,861 | 5,271 | 5,647 | 6,101 | 5,357 | 4,353 | 3,161 | -127 | -784 | -1,297 | -1,739 | 0 | 0 | 0 |
Net loss | |||||||||||||
-145,919 | -140,729 | -133,280 | -114,963 | -86,579 | -74,064 | -59,088 | -51,418 | -43,808 | -33,709 | -29,569 | 0 | 0 | 0 |
Net loss attributable to common stockholders | |||||||||||||
- | - | -133,280 | -114,963 | - | -74,064 | -59,176 | -52,919 | -46,515 | -37,582 | -34,154 | 0 | 0 | 0 |
Net loss per share attributable to common stockholders, basic and diluted | |||||||||||||
-0.78 | -0.74 | -1.04 | -1.24 | -0.84 | -0.74 | -0.52 | -0.52 | -0.60 | 0.48 | -1.78 | -0.79 | -0.74 | -0.71 |
Weighted-average common shares outstanding, basic and diluted | |||||||||||||
44,049 | 42,278 | 34,541 | 34,452 | 34,417 | 34,514 | 34,256 | 27,960 | 27,284 | 26,275 | 6,404 | 10,196 | 10,196 | 10,196 |
Other comprehensive loss: | |||||||||||||
Net loss | |||||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - | - | - | - |
Unrealized gain on marketable securities | |||||||||||||
0 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Comprehensive loss | |||||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - | - | - | - |